Oscar Health shares at $23.60 have risen above the average analyst 12-month target of $21.20, putting the stock roughly 11% above consensus. The article centers on what analysts may do when price moves through their target, making this primarily an analyst-ratings and market-technicals story rather than a new fundamental update.
Oscar Health shares at $23.60 have risen above the average analyst 12-month target of $21.20, putting the stock roughly 11% above consensus. The article centers on what analysts may do when price moves through their target, making this primarily an analyst-ratings and market-technicals story rather than a new fundamental update.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
